INTERNATIONAL PATENT: EMMYON, INC. FILES APPLICATION FOR "FUROSTAN-3-OL DERIVATIVES FOR THE TREATMENT OF OBESITY AND DIABETES"

GENEVA, May 6 -- EMMYON, INC. (E152 Bio Ventures Center2746 Foxwoods Ln SWRochester, Minnesota 55902) filed a patent application (PCT/US2024/052539) for "FUROSTAN-3-OL DERIVATIVES FOR THE TREATMENT OF OBESITY AND DIABETES" on Oct 23, 2024. With publication no. WO/2025/090589, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TALLEY, John (6519 Walsh StreetSt. Louis, Missouri 63109)

Abstract: The use of a compound of formula (I) to treat adiposity, obesity, and diabetes is disclosed. Compositions comprising the methanesul...